Kenichiro Sugiyama

Safety, Tolerability, and Pharmacokinetics of the Novel Adenosine A2A Antagonist/Inverse Agonist KW‐6356 Following Single and Multiple Oral Administration in Healthy Volunteers

Y. Kagawa, Yoshinori Nagata, M. Hruska, 2023, Clinical pharmacology in drug development.